Cerus (CERS) Stock
Cerus (CERS) closed at $1.99 on Nov 13, 2026; its Tenet Score is 33 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $1.99
- Nov 13, 2026
- Market cap
- $400.9M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 1.47 – 3.47
- low → high
- Tenet Score
- 33/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
CERUS CORP scores 33/100. Weak. Value is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
No dividend. Cash stays in the business.
13F flows & insider trades land here.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replicatio…
Common questions
What sector and industry is Cerus in?
Cerus is in the Healthcare sector and the Drugs industry.
What is Cerus' Tenet Score?
Cerus' Tenet Score is 33 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




